Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 Jul;39(7):656–662. doi: 10.1136/jnnp.39.7.656

Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome.

C D Frith, E C Johnston, M H Joseph, R J Powell, R W Watts
PMCID: PMC492397  PMID: 792398

Abstract

5-Hydroxytryptophan (5-HTP) treatment of a single case of Lesch-Nyhan syndrome showing compulsive self-mutilation, athetoid movements, and characteristic clinical biochemical picture was studied on a double-blind basis. 5-HTP or placebo was administered for seven fortnightly treatment blocks. 5-HTP produced a significant reduction of athetoid movement and a sedative effect but did not improve the patient's mood or reduce self-mutilation.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold W. J., Meade J. C., Kelley W. N. Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome. J Clin Invest. 1972 Jul;51(7):1805–1812. doi: 10.1172/JCI106982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Craft J. A., Dean B. M., Watts R. W., Westwick W. J. Studies on human erythrocyte IMP: pyrophosphate phosphoribosyltransferase. Eur J Biochem. 1970 Aug;15(2):367–373. doi: 10.1111/j.1432-1033.1970.tb01017.x. [DOI] [PubMed] [Google Scholar]
  3. Duker P. Behaviour control of self-biting in a Lesch-Nyhan patient. J Ment Defic Res. 1975 Mar;19(1):11–19. doi: 10.1111/j.1365-2788.1975.tb01252.x. [DOI] [PubMed] [Google Scholar]
  4. Fox I. H., Kelley W. N. Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties. J Biol Chem. 1971 Sep 25;246(18):5739–5748. [PubMed] [Google Scholar]
  5. Goldberg D. P., Cooper B., Eastwood M. R., Kedward H. B., Shepherd M. A standardized psychiatric interview for use in community surveys. Br J Prev Soc Med. 1970 Feb;24(1):18–23. doi: 10.1136/jech.24.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gordon R. B., Thompson L., Emmerson B. T. Erythrocyte phosphoribosylpyrophosphate concentrations in heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 1974 Oct;23(10):921–927. doi: 10.1016/0026-0495(74)90041-9. [DOI] [PubMed] [Google Scholar]
  7. Gutensohn W., Guroff G. Hypoxanthine-guanine-phosphoribosyl-transferase from rat brain (purification, kinetic properties, development and distribution). J Neurochem. 1972 Sep;19(9):2139–2150. doi: 10.1111/j.1471-4159.1972.tb05123.x. [DOI] [PubMed] [Google Scholar]
  8. Hadden J. W., Hadden E. M., Haddox M. K., Goldberg N. D. Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc Natl Acad Sci U S A. 1972 Oct;69(10):3024–3027. doi: 10.1073/pnas.69.10.3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harkness R. A., Nicol A. D. Plasma uric acid levels in children. Arch Dis Child. 1969 Dec;44(238):773–778. doi: 10.1136/adc.44.238.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaufman J. M., Greene M. L., Seegmiller J. E. Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. J Pediatr. 1968 Oct;73(4):583–592. doi: 10.1016/s0022-3476(68)80274-4. [DOI] [PubMed] [Google Scholar]
  11. Kebabian J. W., Blood F. E., Steiner A. L., Greengard P. Neurotransmitters increase cyclic nucleotides in postganglionic neurons: immunocytochemical demonstration. Science. 1975 Oct 10;190(4210):157–159. doi: 10.1126/science.241121. [DOI] [PubMed] [Google Scholar]
  12. LESCH M., NYHAN W. L. A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. Am J Med. 1964 Apr;36:561–570. doi: 10.1016/0002-9343(64)90104-4. [DOI] [PubMed] [Google Scholar]
  13. LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
  14. Mizuno T. I., Yugari Y. Letter: Self mutilation in Lesch-Nyhan syndrome. Lancet. 1974 Apr 20;1(7860):761–761. doi: 10.1016/s0140-6736(74)92990-0. [DOI] [PubMed] [Google Scholar]
  15. Randrup A., Munkvad I. Role of catecholamines in the amphetamine excitatory response. Nature. 1966 Jul 30;211(5048):540–540. doi: 10.1038/211540a0. [DOI] [PubMed] [Google Scholar]
  16. Rockson S., Stone R., Van der Weyden M., Kelley W. N. Lesch-Nyhan syndrome: evidence for abnormal adrenergic function. Science. 1974 Dec 6;186(4167):934–935. doi: 10.1126/science.186.4167.934. [DOI] [PubMed] [Google Scholar]
  17. Sandler J. A., Clyman R. I., Manganiello V. C., Vaughan M. The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3',5'-monophosphate in human monocytes. J Clin Invest. 1975 Feb;55(2):431–435. doi: 10.1172/JCI107948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Watts R. W., McKeran R. O., Brown E., Andrews T. M., Griffiths M. I. Clinical and biochemical studies on treatment of Lesch-Nyhan syndrome. Arch Dis Child. 1974 Sep;49(9):693–702. doi: 10.1136/adc.49.9.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weight F. F., Petzold G., Greengard P. Guanosine 3',5'-monophosphate in sympathetic ganglia: increase assoicated with synaptic transmission. Science. 1974 Dec 6;186(4167):942–944. doi: 10.1126/science.186.4167.942. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES